LOG IN

Members and suppliers: Join our online community

Access our full library of resources, register for events and webinars and share audits and other assessments

We host conferences, webinars and training for members, suppliers and auditors. Here you will find information on our events as well as relevant external events.

This event was published on 25 August
Registration Open
2025 PSCI China Supplier Conference 中国供应商大会 (上海)

2025 PSCI China Supplier Conference 中国供应商大会 (上海)

Conference | 17–19 Nov 2025

We are pleased to invite you to register for the 2025 PSCI China Supplier Conference.

我们诚邀您注册参加2025年PSCI中国供应商大会(上海)。

The 2025 PSCI China Supplier Conference will continue to focus on supplier capability building in the areas of Health and safety, Environment, Human rights, Governance and Management Systems, and Ethics.

2025年 PSCI 年度供应商专业发展大会将继续围绕PSCI原则,关注供应商在健康与安全环境人权治理与管理体系商业道德方面的能力建设。我们邀请PSCI成员、供应商及行业专家为供应商解读上述领域的最佳实践,并探讨行业面临的挑战,也使供应商有机会了解同行、合作伙伴在相关领域的优秀实践,进一步发展专业知识。

若您有注册相关问题,请联系秘书处Colin Zhu(colin.zhu@slrconsulting.org).

  • 会议语言 Language: 中文 Mandarin
  • 会议日期 Date: 11月17日 ,11月 18日,11月19日 17th - 19th November
  • 会议时间 Time: 9:30-18:00 北京时间 9:30-18:00 Beijing time
  • 地点 Location: 漕河泾会议中心(上海市徐汇区古美路1528号A7号楼)Caohejing Conference Centre (Buildng A7, No.1528 Gumei Road, Xuhui, Shanghai)

推荐附近住宿酒店:上海漕河泾万丽酒店(距会议中心步行3分钟内)
Recommended hotel: Shanghai Caohejing Renaissance Hotel (3 mins walk from the conference centre)

目前多个议题的演讲嘉宾/讲师正在招募中,如您愿意作为讲师/参与互动分享,请联系PSCI秘书处 Danran Chen (danran.chen@slrconsulting.org);Colin Zhu (colin.zhu@slrconsulting.org)。

嘉宾/讲师需求详见以下议程:

  • 报名指南 How to register: 点击下方REGISTER NOW > 用英文填写报名信息(PSCI注册用户请先行登录,系统将自动填写您的信息)> 勾选报名场次 > 点击右下角 ‘Register' 提交报名。为准确统计每天的参会人数,如您仅参加第一天/第二天/第三天的会议,请按需准确选择。

报名成功后,您的报名邮箱将收到系统自动发出的确认邮件。参会指引信息将于10月中发送至您的报名登记邮箱。您可点击如下 “Add to Calendar” 添加至日历提醒。若有任何注册相关问题,请联系秘书处 danran.chen@slrconsulting.org; colin.zhu@slrconsulting.org。

11月17日: PSCI 最新发展 Introduction | 管理体系 Mgmt System | 劳工与商业道德 Human Rights & Ethics
17 Nov 2025 09:30–17:30 Beijing

建议参会人员:公司管理层、人力资源部门
Recommended for: Senior management, HR departments

会议第一天,我们将邀请PSCI成员公司及供应商嘉宾进行主题演讲,旨在提高供应商在公司治理、商业道德、劳工权益等方面的管理水平。

演讲内容将包含:PSCI最新动态;管理成熟度模型实践;ESG管理搭建 ;制药供应链中劳工权益的要求及具体实施方法;信息安全管理实践。更多内容正在筹备中。部分话题正在招募讲师,如您有意主讲,请联系秘书处Danran (danran.chen@slrconsulting.org)和Colin (colin.zhu@slrconsulting.org)

暂定议程 Tentative agenda:

  • 观众注册 Registration
  • PSCI董事会演讲(暂定) Board Speech (TBD)
  • PSCI最新动态 Updates on PSCI
  • 管理成熟度模型实践 Practices of Management Maturity Model
  • ESG管理体系搭建 Building an ESG Management System
  • 制药供应链中劳工权益的要求及具体实施方法 Labour Right Requirements in Pharmaceutical Supply Chains & Implementation Measures (讲师招募中,讲师也可围绕此话题方向自拟其他话题)
  • 劳工话题待定 (讲师招募中)
  • 信息安全管理实践 Management Practices of Information Safety (讲师招募中,讲师也可围绕此话题方向自拟其他话题)

11月18日: 环境 Environment | 减碳 Decarbonisation | 审计 Audit
18 Nov 2025 09:00–17:30 Beijing

建议参会人员:公司管理层、环境管理部门
Recommended for: Senior management, Environment departments

会议第二天,我们将邀请PSCI成员公司及供应商嘉宾进行主题演讲,旨在提高供应商在环境管理、节能减排等方面的管理水平,并了解2024年度的审计发现情况。

演讲内容将包含:能源效率提升的实施路径;通过循环经济推动节能减排的实践分享 ;环境设备的碳排放及应对 ;废水API取样与分析的重点与案例分享;水资源管理和减碳结合的最佳实践;2024审计发现项解读 ;从审计员的角度洞察审计发现项。更多内容正在筹备中。部分话题正在招募讲师,如您有意主讲,请联系秘书处Danran (danran.chen@slrconsulting.org)和Colin (colin.zhu@slrconsulting.org)

暂定议程 Tentative agenda:

  • Registration 观众注册
  • 能源效率提升的实施路径 Implementation Approaches of Energy Efficiency Improvement(讲师招募中,讲师也可围绕此话题方向自拟其他话题
  • 通过循环经济推动节能减排的实践分享 Practices of Decarbonisation Through Circular Economy(讲师招募中,讲师也可围绕此话题方向自拟其他话题
  • 环境设备的碳排放及应对 Addressing GHG Emission Associated with Environmental Facilities (讲师招募中,讲师也可围绕此话题方向自拟其他话题
  • 圆桌讨论:废水API取样与分析的重点与案例分享 Round Table Session: Study and Practice Sharing of API Sampling and Analyses in Wastewater
  • 水资源管理和减碳结合的最佳实践 Best Practices of Combing Water Management and Decarbonisation
  • 2024审计发现项解读 2024 Audit Finding Analysis
  • 圆桌讨论:从审计员的角度洞察审计发现项 Round Table Sessions: Insights on Audit Findings from Auditors

11月19日: 安全总览 General Safety | 工业卫生 Industrial Hygiene | 过程安全 Process Safety
19 Nov 2025 09:00–17:30 Beijing

建议参会人员:健康安全管理部门
Recommended for: Heath & Safety departments

会议第三天,我们将邀请PSCI成员公司及供应商嘉宾进行主题演讲,旨在提高供应商在健康安全等方面的管理水平。

演讲内容将包含:安全事故案例分享及PSCI过程安全相关审计发现;保护层分析(LOPA)在安全完整性等级(SIL)定级中的应用;制药行业粉尘爆炸参数的测定与除尘系统设计概论;化学品及其危害因素的全流程管理;暴露评估与密闭性测试的差异分享;硬质隔离器的使用和维护。

暂定议程 Tentative agenda:

  • 观众注册 Registration
  • 安全事故案例分享及PSCI过程安全相关审计发现 PSCI Audit Findings on Process Safety and Safety Incident Sharing
  • 保护层分析(LOPA)在安全完整性等级(SIL)定级中的应用 Application of LOPA in SIL Determination
  • 制药行业粉尘爆炸参数的测定与除尘系统设计概论 Overview of Dust Explosion Parameter Measurement and Dust Removal System Design in the Pharmaceutical Industry
  • 化学品及其危害因素的全流程管理 Comprehensive Lifecycle Management of Chemicals and Their Associated Hazard
  • 暴露评估与密闭性测试的差异分享 Sharing of Differences Between Exposure Assessment and Airtightness Testing
  • 硬质隔离器的使用和维护 Operation and Maintenance of Rigid Isolators
Add To Calendar Presentation Proposal

If you have a PSCI account, please log in first so your information will be filled automatically.

All fields are required except where specified. Please enter all information in English.

Full Members

  • Abbott
  • Acino International AG
  • AstraZeneca
  • Aurobindo
  • BASF Pharma
  • Bayer
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Catalent Inc
  • Centrient Pharmaceuticals
  • Coloplast
  • Elanco Animal Health
  • Grunenthal GmbH
  • GSK
  • Haleon
  • Johnson & Johnson
  • Kenvue
  • Lilly
  • Mallinckrodt
  • Merck & Co.
  • Novartis
  • Novo Nordisk
  • Orion
  • Pfizer
  • Piramal
  • Roche
  • Sandoz
  • Sanofi
  • Sartorius
  • Takeda
  • Teva
  • UCB
  • Viatris
  • West Pharmaceutical Services Inc.
  • Zoetis

Associate Members

  • AbbVie
  • Alkem Laboratories
  • Almirall
  • Amgen
  • Amgros
  • Aragen Life Sciences Limited
  • Aspen Pharmacare
  • Bavarian Nordic
  • Baxter
  • Becton Dickinson
  • Biogen
  • Charles River Laboratories
  • Chiesi
  • Chugai Pharmaceutical
  • Cipla
  • CSL Limited
  • Eisai Co., Limited
  • Esteve
  • Evolan Pharma AB
  • Fabbrica Italiana Sintetici S.p.a.
  • Fagron
  • Fosun Pharma
  • Fresenius Kabi
  • Gilead
  • Hameln Pharma
  • Immedica Pharma
  • IOI Oleo
  • Karo Healthcare
  • Kyowa Kirin
  • LEO Pharma
  • Mallax Pharmaceutical
  • Merck KGaA
  • Moderna
  • Nordic Group B.V.
  • Ono Pharmaceuticals
  • Organon
  • Orifarm
  • Perrigo Company
  • Sai Life Sciences
  • Shionogi
  • SK Biopharmaceuticals
  • Sobi
  • STADA
  • Sterling Pharma Solutions
  • ten23 health
  • Tiefenbacher Group
  • Vertex
  • Vetoquinol
  • Xellia Pharmaceuticals
  • Zentiva

Please indicate which sessions you plan to attend:

17 Nov 2025

18 Nov 2025

19 Nov 2025

We will not pass on these details to third parties and will use them only to contact you about this event, or other PSCI events we think you may be interested in.

Please contact us if you find you can no longer attend.

I understand that these details will be used by the PSCI to identify me and to send me communications relating to this, and future, PSCI events.

Leave this field blank if you are a human.
Registration Closes: 31 Oct 2025
If you have a user account, please log in before registering.
  • Human Rights & Labor
  • Health & Safety
  • Process Safety
  • Management Systems
  • Data Security
  • Occupational Health & Industrial Hygiene
  • Waste Management
  • Water Use & Management
  • Pharmaceuticals In The Environment
  • Anti-Microbial Resistance
  • Decarbonization
  • Audit Program
This event was published on 27 June
Registration Open
PSCI Decarbonization Summit 2025

PSCI Decarbonization Summit 2025

Conference | 22–23 Oct 2025

Register now to attend the PSCI summit on the critical topic of decarbonization

The agenda is now available

"PSCI has 85 Member companies across the Pharma, Biotech and Med-Tech sector, representing around $1.2 trillion USD or 70% of global sector revenues. We act as one voice for the industry and have come together to give you – our suppliers – a clear unified message on how we will together accelerate action on decarbonization.

"Join us for the PSCI Decarbonization Summit on October 22nd and 23rd 2025, to hear the message from our Members, understand how to build your capability no matter your maturity and set an achievable roadmap to turn decarbonization plans into action by 2030."

Robert Williams, AstraZeneca, PSCI Chair

A sneak peak of what to expect:

  • A tailored agenda for your maturity: From getting to grips with the basics of calculating greenhouse gas baseline emissions, to embedding climate standards across your value chain and developing a robust Net Zero Roadmap That Meets SBTi Criteria, the PSCI Decarbonization Summit has something for everyone.
  • Peer-to-peer learning: Have an innovative solution to accelerate decarbonization? Day 2 of the Summit gives you the opportunity to share existing solutions with PSCI Members to share best practice and drive decarbonization.

The full agenda will be available soon and this summit will take place virtually.

Please contact us with any questions.

Type
Conference
Date
22–23 Oct 2025
Language
English
Add To Calendar Download Agenda

If you have a PSCI account, please log in first so your information will be filled automatically.

All fields are required except where specified. Please enter all information in English.

Full Members

  • Abbott
  • Acino International AG
  • AstraZeneca
  • Aurobindo
  • BASF Pharma
  • Bayer
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Catalent Inc
  • Centrient Pharmaceuticals
  • Coloplast
  • Elanco Animal Health
  • Grunenthal GmbH
  • GSK
  • Haleon
  • Johnson & Johnson
  • Kenvue
  • Lilly
  • Mallinckrodt
  • Merck & Co.
  • Novartis
  • Novo Nordisk
  • Orion
  • Pfizer
  • Piramal
  • Roche
  • Sandoz
  • Sanofi
  • Sartorius
  • Takeda
  • Teva
  • UCB
  • Viatris
  • West Pharmaceutical Services Inc.
  • Zoetis

Associate Members

  • AbbVie
  • Alkem Laboratories
  • Almirall
  • Amgen
  • Amgros
  • Aragen Life Sciences Limited
  • Aspen Pharmacare
  • Bavarian Nordic
  • Baxter
  • Becton Dickinson
  • Biogen
  • Charles River Laboratories
  • Chiesi
  • Chugai Pharmaceutical
  • Cipla
  • CSL Limited
  • Eisai Co., Limited
  • Esteve
  • Evolan Pharma AB
  • Fabbrica Italiana Sintetici S.p.a.
  • Fagron
  • Fosun Pharma
  • Fresenius Kabi
  • Gilead
  • Hameln Pharma
  • Immedica Pharma
  • IOI Oleo
  • Karo Healthcare
  • Kyowa Kirin
  • LEO Pharma
  • Mallax Pharmaceutical
  • Merck KGaA
  • Moderna
  • Nordic Group B.V.
  • Ono Pharmaceuticals
  • Organon
  • Orifarm
  • Perrigo Company
  • Sai Life Sciences
  • Shionogi
  • SK Biopharmaceuticals
  • Sobi
  • STADA
  • Sterling Pharma Solutions
  • ten23 health
  • Tiefenbacher Group
  • Vertex
  • Vetoquinol
  • Xellia Pharmaceuticals
  • Zentiva

We will not pass on these details to third parties and will use them only to contact you about this event, or other PSCI events we think you may be interested in.

Please contact us if you find you can no longer attend.

I understand that these details will be used by the PSCI to identify me and to send me communications relating to this, and future, PSCI events.

Leave this field blank if you are a human.
Registration Closes: 22 Oct 2025
If you have a user account, please log in before registering.
This event was published on 8 July
Registration Open
PSCI India Supplier Conference 2025

PSCI India Supplier Conference 2025

Conference | 24–26 Sep 2025

Join us for the PSCI Annual India Pharma Industry Conference & Exhibition:

We are excited to invite you to join us from 24-26 September in Chandigarh for an PSCI Annual India Conference & Exhibition. This event offers a platform to delve into best practices and emerging trends related to the PSCI Principles. Additionally, it provides excellent opportunities for networking with industry peers.

We are delighted to unveil the theme of this year's conference and exhibitions:

Building Resilient Value Chains through Collaborative Leadership in India

  • Date: 24-26 September 2025
  • Time: 09:30 - 17:00
  • Language: English

Location:

Exhibition: The conference will also feature an exhibition highlighting pharmaceutical best practices and success stories aligned with the PSCI Principles. These exhibitions aim to extend discussions beyond the conference room, fostering impactful collaborations and practical approaches to addressing common industry challenges.

Workshop: This year, we are thrilled to announce a workshop centred around the conference theme. This workshop is designed to delve deeper into the topics and themes of our annual conference, providing an in-depth exploration and fostering meaningful discussions.

Contact Information: For any queries or doubts, please reach out to:

  • Subhash Babu, ISS (+91 9327547484) - First point of contact & event organizer
  • Aditya Shirodkar, Abbott (+91 7030129399) - Secondary contact & PSCI India Team Lead

Additional Information: We request that each organization appoints a maximum of 2 participants (in exceptional cases, 3 participants).

The conference agenda will be shared in due course. We look forward to your participation and to making this event a great success together!

Glimpse of the 2024 conference & exhibition: video link

Type
Conference
Date
24–26 Sep 2025
Language
English

If you have a PSCI account, please log in first so your information will be filled automatically.

All fields are required except where specified. Please enter all information in English.

Full Members

  • Abbott
  • Acino International AG
  • AstraZeneca
  • Aurobindo
  • BASF Pharma
  • Bayer
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Catalent Inc
  • Centrient Pharmaceuticals
  • Coloplast
  • Elanco Animal Health
  • Grunenthal GmbH
  • GSK
  • Haleon
  • Johnson & Johnson
  • Kenvue
  • Lilly
  • Mallinckrodt
  • Merck & Co.
  • Novartis
  • Novo Nordisk
  • Orion
  • Pfizer
  • Piramal
  • Roche
  • Sandoz
  • Sanofi
  • Sartorius
  • Takeda
  • Teva
  • UCB
  • Viatris
  • West Pharmaceutical Services Inc.
  • Zoetis

Associate Members

  • AbbVie
  • Alkem Laboratories
  • Almirall
  • Amgen
  • Amgros
  • Aragen Life Sciences Limited
  • Aspen Pharmacare
  • Bavarian Nordic
  • Baxter
  • Becton Dickinson
  • Biogen
  • Charles River Laboratories
  • Chiesi
  • Chugai Pharmaceutical
  • Cipla
  • CSL Limited
  • Eisai Co., Limited
  • Esteve
  • Evolan Pharma AB
  • Fabbrica Italiana Sintetici S.p.a.
  • Fagron
  • Fosun Pharma
  • Fresenius Kabi
  • Gilead
  • Hameln Pharma
  • Immedica Pharma
  • IOI Oleo
  • Karo Healthcare
  • Kyowa Kirin
  • LEO Pharma
  • Mallax Pharmaceutical
  • Merck KGaA
  • Moderna
  • Nordic Group B.V.
  • Ono Pharmaceuticals
  • Organon
  • Orifarm
  • Perrigo Company
  • Sai Life Sciences
  • Shionogi
  • SK Biopharmaceuticals
  • Sobi
  • STADA
  • Sterling Pharma Solutions
  • ten23 health
  • Tiefenbacher Group
  • Vertex
  • Vetoquinol
  • Xellia Pharmaceuticals
  • Zentiva

We will not pass on these details to third parties and will use them only to contact you about this event, or other PSCI events we think you may be interested in.

Please contact us if you find you can no longer attend.

I understand that these details will be used by the PSCI to identify me and to send me communications relating to this, and future, PSCI events.

Leave this field blank if you are a human.
Registration Closes: 20 Sep 2025
If you have a user account, please log in before registering.
This event was published on 26 August
Registration Open
PSCI Webinar: Introductory Course to LCAs  in the Pharmaceutical Sector

PSCI Webinar: Introductory Course to LCAs in the Pharmaceutical Sector

Webinar | 16 Sep 2025 15:00–16:00 London

About:
This webinar will introduce the recently launched introductory course to LCAs in the pharmaceutical sector. It will provide an overview of the training and how to access it; summarise key content of the training including the importance of LCAs in the pharmaceutical sector, the fundamentals of LCAs, the key steps to conducting an LCA, and the role of suppliers in supporting LCA.

It will also explain why it is important that suppliers complete this training before the launch of PAS 2090:2025, the global LCA standard for the pharmaceutical industry, in October.

Finally, the webinar will also provide a brief update on progress in the development of the pharmaceutical life cycle inventory (LCI) database in ecoinvent and the development of a pharma LCA tool, both of which will be accessible to suppliers and will serve to support the adoption of LCA practices across the pharmaceutical sector and supply chain. You will hear from Sustainability and LCA experts from Novartis and Sanofi.

Speakers:

  • Leadership introduction from José-Francisco Vallejo Carrera, Global Head Environment & Environmental Sustainability, Sanofi.
  • Andrej Szijjarto, Sustainable Product Design Lead at Novartis.
  • Sarah Arias-Zeballos, is Global Eco-design Leader at Sanofi, where she drives environmental medicines sustainability strategy, digital Eco-design innovation, and global transformation. She leads the business development of Sanofi’s product environmental footprint platform (EDDi), integrates Eco-design/ Life Cycle Assessment strategy into Pharma R&D and Commercial medicine pipelines, and pioneers GenAI applications in sustainability. Sarah also champions global stakeholder engagement and Eco-design training across regions, advancing Sanofi’s leadership in environmental sustainable healthcare.
Type
Webinar
Date
16 Sep 2025 15:00–16:00 London
Language
English
This event was published on 21 July
PSCI Webinar: Dust Hazard Assessment and Controls in the Pharma Industry

PSCI Webinar: Dust Hazard Assessment and Controls in the Pharma Industry

Webinar | 7 Aug 2025 15:00–16:30 Kolkata

Understanding dust hazard, assessment and control measures to enhance people and plant safety. In pharmaceutical manufacturing, dust is not just a housekeeping issue — it is a serious safety concern. Many active pharmaceutical ingredients (APIs) and excipients are combustible when finely powdered. If these dusts accumulate or are dispersed in the air, they can pose a significant explosion hazard with serious risk to life and property. Based on of review of the health & safety findings from 180 PSCI audits in 2023, 22% findings were related to Process safety, including explosion risk.

Dust Hazard Assessment, or DHA, is a systematic approach to identifying and mitigating these risks. This webinar will help you gain a better understanding of dust hazard, assessment, and control measures to protect your people and facility from potentially catastrophic explosions and to meeting regulatory and industry safety standards. The following topics will be covered during the webinar:

  • Key definitions
  • Conditions for fire / explosion
  • Chemical flammability properties
  • Typical Ignition Sources
  • Control of flammable atmospheres
  • Dust Hazard Assessment (DHA)
  • Key safety measures to mitigate dust hazard

Suggested Audience: PSCI Suppliers and PSCI members. HSE, Process Safety, Quality and Operations personnel will benefit from attending this webinar

Speaker: Mr. Jitendra Kumar - CEO, FET Solutions Pvt. Ltd. Jitendra is a B.Tech. in Chemical Engineering from IIT Delhi. He has been working in the field of Process Safety for more than 3 decades. He has provided extensive PSM support to numerous sectors such as Pharmaceuticals, Bulk & Fine Chemicals, Agrochemicals, Oil & Gas (onshore and offshore), Petrochemicals, Fertilizers, Food, Engineering, Metallurgy, Cosmetics and more.

He is an expert in conducting HAZID, HAZOP, QRA, FERA, Radiation & Dispersion, MCA, SIL, LOPA, Vent sizing, Chemical Reaction Hazards, Dust Hazards, Electrostatics, Hazardous Area Classification, F&G mapping, Fire fighting system adequacy and design, RAM and Accident Investigation amongst others.

Type
Webinar
Date
7 Aug 2025 15:00–16:30 Kolkata
Language
English
This event is in the past
  • Process Safety
  • Spills & Releases
  • Safety - High Risk Areas
This event was published on 13 June
PSCI Webinar: Strategies for Accurate API Exposure Monitoring

PSCI Webinar: Strategies for Accurate API Exposure Monitoring

Webinar | 5 Aug 2025 14:00–15:00 Amsterdam

Webinar Description:
Over 50% of API and surrogate exposure monitoring results are considered unreliable. Accurate, reproducible, and representative monitoring and analysis of API exposures are essential for protecting worker health and developing effective exposure control strategies. Inaccurate results can lead to significant risks for occupational health and undermine the effectiveness of safety measures.

This webinar will offer practical guidance on sampling strategies and methods to support accurate API exposure assessment, in alignment with PSCI’s principles on health and safety. Drawing on insights from over 5,000 API and surrogate exposure monitoring results, the session will help participants strengthen their industrial hygiene programs with evidence-based best practices and real-world lessons learned.

Speakers:

  • Maharshi Mehta, CIH, CSP, FAIHA: Global Leader at International Safety Systems, Inc. 30+ years of conducting industrial hygiene assessment and training at 200+ pharma industries globally. Recepient of Yant Award from American Industrial Hygiene Association and Lifetime Achievement Award from Board for Global EHS Credentialling for promoting occupational hygiene globally.
  • Ankit Sharma, CIH, LFOH, Associate Director, International Safety Systems, Inc. Conducted industrial hygiene assessments and training at more than 50 pharma sites globally. Ankit and his team collected, interpreted and analysed more than 5000 surrogate and API exposure monitoring results. Provided potent compound control solutions and conducted practical training on potent compounds.
Type
Webinar
Date
5 Aug 2025 14:00–15:00 Amsterdam
Language
English
This event is in the past
  • Water Use & Management
This event was published on 16 June
UPDATED: Technical Workshop for Indian-based Suppliers: Process Safety & Industrial Hygiene

UPDATED: Technical Workshop for Indian-based Suppliers: Process Safety & Industrial Hygiene

Conference | 16 Jul 2025 09:00–18:00 Kolkata

Please note the updated topic focus for this workshop is now Process Safety and Industrial Hygiene.

If you have registered for the workshop and are no longer interested or able to attend, please contact us to cancel your registration.

The workshop will focus on the topics of Process Safety and Industrial Hygiene, which have been selected considering the needs of the regional pharma industry in India.

The session is aimed at EHS, Safety and Engineering professionals from Pharma manufacturing industries. There is no registration fee for participating in this event.

Please note that registration for this workshop is limited to 50 participants and the event will take place in-person. No virtual option is available.

We are pleased to be joined by speakers from M/S GVS Cibatech and M/S RECOH EHS who will deliver these sessions.

Agenda

  • 09:00-09:30: Registration & Breakfast
  • 09:30-10:15: Opening including PSCI Introduction
  • 10:15-11:30: Technical Session – 1 (Chemical Reaction hazards – M/s GVS Cibatech)
  • 11:30-11:45: 1st Tea / Coffee break
  • 11:45-13:15: Technical Session – 2 (Chemical Reaction Risk Assessment & Controls – M/S GVS Cibatech)
  • 13:15-14:15: Lunch
  • 14:15-15:30: Technical Session – 3 (Industrial Hygiene Risk Assessment – M/S RECOH EHS)
  • 15:30-15:45: 2nd Tea / Coffee break (Hi-Tea)
  • 15:45-17:30: Technical Session – 4 (Industrial Hygiene Risk Assessment & Controls– M/s RECOH EHS)
  • 17:30-18:00: Vote of thanks
Type
Conference
Date
16 Jul 2025 09:00–18:00 Kolkata
Language
English
This event is in the past
This event was published on 6 May
Webinar: 阿斯利康无锡供应工厂节能减排实践分享 AstraZeneca Wuxi Site's Emission Reduction & Energy Saving Practices

Webinar: 阿斯利康无锡供应工厂节能减排实践分享 AstraZeneca Wuxi Site's Emission Reduction & Energy Saving Practices

Webinar | 5 Jun 2025 16:00–17:00 Beijing

本线上研讨会由PSCI中国小组筹备;会议语言为中文。
The webinar is sponsored by PSCI China regional team.
The presentation will be delivered in Mandarin.

研讨会话题
阿斯利康无锡供应工厂节能减排实践分享: 从战略到实践的可持续探索

注册/登录PSCI账户后即可报名,报名将于6月2日下午17:00点截止。参会指引邮件将于6月3日发出。

分享嘉宾
韦雁翔 - 阿斯利康无锡供应工厂 Associate Director Utility Management

线上研讨会话题简介
本次分享将介绍阿斯利康无锡供应工厂在节能减排方面的实际经验与探索过程

您将收获

  • 实践视角:不仅限于理念,深入了解医药供应链健谈过程中的现实挑战与应对方式
  • 战略对接:了解全球“零碳”目标如何转化为工厂的具体行动,平衡绿色转型与运营效率
  • 可借鉴的框架:涵盖技术改造、数字化转型和管理创新等多方面案例,多维度展现可参考的落地框架
  • 行业交流:与供应链及可持续发展领域从业者共同探讨行业低碳转型的趋势与实践路径

会议语言
本次研讨会会议语言为中文。

如您无法正常查看下方注册按钮,请您尝试更换浏览器打开此页面。

Topic
AstraZeneca Wuxi Site's Emission Reduction & Energy Saving Practices: From Strategy to Action

Overview
We will share Wuxi Site's best practices in energy conservation and emission reduction

You'll Gain

  • Firsthand examples of site-level energy conservation and emission reduction efforts
  • Data-informed approaches to energy efficiency and carbon management
  • Insights into cross-functional collaboration to support green transformation at the factory level

Please register your attendance before 2nd June. We'll send out meeting instructions & link on 3rd June.

Your Presenter
David Wei, Associate Director Utility Management at AstraZeneca Wuxi Site

Type
Webinar
Date
5 Jun 2025 16:00–17:00 Beijing
Language
Mandarin
This event is in the past

Key Events

Webinars